Morning Market Movers

Chembio Diagnostics CEMI gained 21.56% to $4.85 after the company reported that it has partnered with Integrated BioTherapeutics to develop point-of-care diagnostic tests for Ebola and Febrile Illness. Alexza Pharmaceuticals ALXA shares surged 16.70% to $2.65. Ferrer purchased $8 million of Alexza common stock through new investment and elimination of potential milestone payments. NQ Mobile NQ shares jumped 14.21% to $10.21 after the company filed its SEC Form 20-F,l which showed full compliance and no attempts to delete documents. Digital Power DPW shares gained 11.89% to $2.07 after the company reported that it has been awarded an additional $1.6 million defense export order. Prosensa Holding N.V. RNA shares climbed 11.66% to $13.41 on the FDA requirement of additional data from Sarepta on Eteplirsen. Vanda Pharmaceuticals VNDA shares surged 9.27% to $12.14 on Q3 results. Vanda Pharma posted a quarterly loss of $0.64 per share on revenue of $10.90 million. Novavax NVAX shares surged 6.35% to $5.46 after the company announced Ebola vaccine development program at the 8th Vaccine And ISV Conference in Philadelphia. CorMedix CRMD shares gained 4.25% to $1.89 after the company received an approval from the FDA to initiate a clinical trial for Neutrolin in the US. Micron Technology MU rose 3.04% to $32.01 after the company announced a new $1 billion stock repurchase authorization.